In 2018, Liu et al. (8) demonstrated that preoperative serum CEA was an independent prognostic factor of rectal cancer, and elevated serum CEA level presented evidently poorer survival compared with normal serum CEA level in stages I–IV. This evidence concerns the gene CEACAM5 and rectal cancer.